8:01 am Pharmacyclics files Supplemental New Drug Application for IMBRUVICA with Phase III CLL study data
View todays social media effects on PCYC
View the latest stocks trending across Twitter. Click to view dashboard
See who Pharmacyclics is hiring next, click here to view
